首页> 外文期刊>Journal of biomedical materials research, Part A >Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small-diameter blood vessel: Tunable elasticity and anticoagulation property
【24h】

Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small-diameter blood vessel: Tunable elasticity and anticoagulation property

机译:肝素化的PLLA / PLCL纳米纤维支架可用于小直径血管的潜在工程:可调节的弹性和抗凝性

获取原文
获取原文并翻译 | 示例
           

摘要

The success of tissue engineered vascular grafts depends greatly on the synthetic tubular scaffold, which can mimic the architecture, mechanical, and anticoagulation properties of native blood vessels. In this study, small-diameter tubular scaffolds were fabricated with different weight ratios of poly(l-lactic acid) (PLLA) and poly(l-lactide-co--caprolactone) (PLCL) by means of thermally induced phase separation technique. To improve the anticoagulation property of materials, heparin was covalently linked to the tubular scaffolds by N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide coupling chemistry. The as-prepared PLLA/PLCL scaffolds retained microporous nanofibrous structure as observed in the neat PLLA scaffolds, and their structural and mechanical properties can be fine-tuned by changing the ratio of two components. The scaffold containing 60% PLCL content was found to be the most promising scaffold for engineering small-diameter blood vessel in terms of elastic properties and structural integrity. The heparinized scaffolds showed higher hydrophilicity, lower protein adsorption ability, and better in vitro anticoagulation property than their untreated counterparts. Pig iliac endothelial cells seeded on the heparinized scaffold showed good cellular attachment, spreading, proliferation, and phenotypic maintenance. Furthermore, the heparinized scaffolds exhibited neovascularization after subcutaneous implantation into the New Zealand white rabbits for 1 and 2 months. Taken together, the heparinized PLLA/PLCL nanofibrous scaffolds have the great potential for vascular tissue engineering application. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1784-1797, 2015.
机译:组织工程化的血管移植物的成功在很大程度上取决于合成的管状支架,该支架可以模仿天然血管的结构,机械和抗凝特性。在这项研究中,通过热诱导相分离技术制造了具有不同重量比的聚(l-乳酸)(PLLA)和聚(l-丙交酯-己内酯)(PLCL)的小直径管状支架。为了提高材料的抗凝性能,肝素通过N-(3-二甲基氨基丙基)-N-乙基碳二亚胺盐酸盐和N-羟基琥珀酰亚胺偶联化学共价连接到管状支架上。如在纯PLLA支架中所观察到的,如此制备的PLLA / PLCL支架保留了微孔纳米纤维结构,并且可以通过改变两种组分的比例来微调其结构和机械性能。就弹性性质和结构完整性而言,包含60%PLCL含量的支架被发现是用于工程小直径血管的最有希望的支架。肝素化的支架比未处理的支架具有更高的亲水性,更低的蛋白质吸附能力和更好的体外抗凝性能。接种在肝素化支架上的猪内皮细胞表现出良好的细胞附着,扩散,增殖和表型维持性。此外,肝素化的支架在皮下植入新西兰白兔1个月和2个月后表现出新血管形成。综上所述,肝素化的PLLA / PLCL纳米纤维支架在血管组织工程应用中具有巨大的潜力。 (c)2014 Wiley Periodicals,Inc.J Biomed Mater Res Part A:103A:1784-1797,2015。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号